Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05132075
Title	Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer (KontRASt-02)
Acronym	KontRASt-02
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Novartis Pharmaceuticals
Indications	lung non-small cell carcinoma
Therapies	JDQ443 Docetaxel
Age Groups:	senior \| adult
Covered Countries	USA \| TUR \| SVN \| ROU \| LBN \| ITA \| ISL \| HUN \| GRC \| FIN \| ESP \| CAN \| AUS \| ARG